Login / Signup

Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer.

Sonia PernasJennifer L GuerrieroSergey NaumenkoShom GoelMeredith M ReganJiani HuBeth T HarrisonFilipa LynceNancy U LinAnn PartridgeAki MorikawaJohn HutchinsonElizabeth A MittendorfArtem SokolovBeth Overmoyer
Published in: Therapeutic advances in medical oncology (2022)
ClinicalTrials.gov identifier: NCT01796197 (https://clinicaltrials.gov/ct2/show/NCT01796197); registered on February 21, 2013.
Keyphrases
  • computed tomography
  • gene expression
  • transcription factor
  • image quality
  • single cell
  • dual energy
  • magnetic resonance imaging
  • young adults
  • breast cancer risk
  • childhood cancer